Lpl Financial LLC Collegium Pharmaceutical, Inc Transaction History

Lpl Financial LLC

$218 Billion
Q3 2024

A detailed history of Lpl Financial LLC transactions in Collegium Pharmaceutical, Inc stock. As of the latest transaction made, Lpl Financial LLC holds 65,539 shares of COLL stock, worth $2.16 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

65,539

Previous 66,709 1.75%

Holding current value

$2.16 Million

Previous $2.15 Million 17.88%

% of portfolio

0.0%

Previous 0.0%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	SELL	$31.4 - $39.07 $36,738 - $45,711	-1,170 Reduced 1.75%	65,539 $2.53 Million
Q2 2024 Aug 07, 2024	SELL	$31.36 - $39.99 $1.35 Million - $1.72 Million	-43,077 Reduced 39.24%	66,709 $2.15 Million
Q1 2024 May 10, 2024	SELL	$31.23 - $40.91 $315,173 - $412,863	-10,092 Reduced 8.42%	109,786 $4.26 Million
Q4 2023 Feb 14, 2024	SELL	$21.16 - $30.8 $199,559 - $290,474	-9,431 Reduced 7.29%	119,878 $3.69 Million
Q3 2023 Nov 13, 2023	SELL	$21.23 - $24.28 $269,896 - $308,671	-12,713 Reduced 8.95%	129,309 $2.89 Million
Q2 2023 Jul 31, 2023	SELL	$21.06 - $24.0 $345,236 - $393,432	-16,393 Reduced 10.35%	142,022 $3.05 Million
Q1 2023 May 10, 2023	BUY	$23.0 - $29.88 $159,896 - $207,725	6,952 Added 4.59%	158,415 $3.8 Million
Q4 2022 Feb 07, 2023	BUY	$16.14 - $23.55 $159,511 - $232,744	9,883 Added 6.98%	151,463 $3.51 Million
Q3 2022 Nov 14, 2022	SELL	$15.46 - $20.1 $392,637 - $510,479	-25,397 Reduced 15.21%	141,580 $2.27 Million
Q2 2022 Aug 12, 2022	SELL	$14.22 - $20.88 $1,535 - $2,255	-108 Reduced 0.06%	166,977 $2.96 Million
Q1 2022 May 16, 2022	BUY	$17.2 - $22.5 $152,220 - $199,125	8,850 Added 5.59%	167,085 $3.4 Million
Q4 2021 Feb 14, 2022	SELL	$17.5 - $21.35 $502,372 - $612,894	-28,707 Reduced 15.36%	158,235 $2.96 Million
Q3 2021 Nov 15, 2021	SELL	$17.75 - $25.39 $114,168 - $163,308	-6,432 Reduced 3.33%	186,942 $3.69 Million
Q2 2021 Aug 13, 2021	SELL	$21.74 - $25.28 $42,632 - $49,574	-1,961 Reduced 1.0%	193,374 $4.57 Million
Q1 2021 May 14, 2021	BUY	$19.25 - $26.1 $22,734 - $30,824	1,181 Added 0.61%	195,335 $4.63 Million
Q4 2020 Feb 12, 2021	SELL	$17.83 - $22.29 $103,057 - $128,836	-5,780 Reduced 2.89%	194,154 $3.89 Million
Q3 2020 Nov 09, 2020	SELL	$15.78 - $20.82 $185,478 - $244,718	-11,754 Reduced 5.55%	199,934 $4.16 Million
Q2 2020 Aug 13, 2020	SELL	$15.49 - $23.51 $25,124 - $38,133	-1,622 Reduced 0.76%	211,688 $3.71 Million
Q1 2020 May 14, 2020	SELL	$13.89 - $25.45 $9,889 - $18,120	-712 Reduced 0.33%	213,310 $3.48 Million
Q4 2019 Feb 14, 2020	BUY	$10.7 - $22.24 $63,354 - $131,683	5,921 Added 2.85%	214,022 $4.41 Million
Q3 2019 Nov 13, 2019	SELL	$10.16 - $13.28 $1,330 - $1,739	-131 Reduced 0.06%	208,101 $2.39 Million
Q2 2019 Aug 09, 2019	BUY	$10.62 - $16.59 $104,160 - $162,714	9,808 Added 4.94%	208,232 $2.74 Million
Q1 2019 May 08, 2019	SELL	$13.58 - $18.72 $21,986 - $30,307	-1,619 Reduced 0.81%	198,424 $3 Million
Q4 2018 Feb 07, 2019	SELL	$14.78 - $19.68 $12,119 - $16,137	-820 Reduced 0.41%	200,043 $3.44 Million
Q3 2018 Nov 14, 2018	BUY	$14.16 - $24.3 $121,181 - $207,959	8,558 Added 4.45%	200,863 $2.96 Million
Q2 2018 Aug 14, 2018	BUY	$21.79 - $28.29 $715,779 - $929,298	32,849 Added 20.6%	192,305 $4.59 Million
Q1 2018 May 15, 2018	BUY	$18.15 - $29.21 $151,933 - $244,516	8,371 Added 5.54%	159,456 $4.07 Million
Q4 2017 Feb 14, 2018	BUY	$9.3 - $19.14 $84,462 - $173,829	9,082 Added 6.4%	151,085 $2.79 Million
Q3 2017 Nov 14, 2017	SELL	$9.15 - $11.97 $3,046 - $3,986	-333 Reduced 0.23%	142,003 $1.49 Million
Q2 2017 Aug 14, 2017	BUY	N/A	142,336	142,336 $1.78 Million

Others Institutions Holding COLL

# of Institutions

254

Shares Held

36.9M

Call Options Held

100K

Put Options Held

21.1K

View Full List

About COLLEGIUM PHARMACEUTICAL, INC

Ticker COLL
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 34,126,200
Market Cap $1.12B
Description
Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ...

More about COLL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lpl Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lpl Financial LLC with notifications on news.

Account

Lpl Financial LLC Collegium Pharmaceutical, Inc Transaction History